A research-based resource from Parasym, creators of the Nuropod wearable device, explores the connection between Long COVID symptoms and the vagus nerve, and how research using Parasym’s AVNT™ waveform has examined fatigue, brain fog, and nervous system activity.
Sacramento, United States, November 19, 2026 -- The team behind Nuropod and neurotechnology research company Parasym has published a research-based resource examining the connection between Long COVID symptoms and the vagus nerve. Released on October 3, 2026, the resource explores how this nerve may be involved in persistent fatigue, brain fog, and other symptoms associated with Long COVID.
The topic is relevant to people experiencing symptoms long after their initial COVID-19 infection. The Centers for Disease Control and Prevention (CDC) reports that Long COVID symptoms can persist for months or years, with fatigue, brain fog, and post-exertional malaise among the most commonly reported. More than 200 symptoms have been identified, illustrating the condition's complexity.
The resource explains how the vagus nerve helps regulate autonomic functions and the body's response to stress. Because Long COVID can involve symptoms affecting multiple body systems, researchers are investigating whether disruptions in autonomic nervous system function contribute to some of these ongoing difficulties.
It also examines noninvasive vagus nerve stimulation, a technique that delivers gentle electrical pulses through the ear to stimulate nerve pathways without surgery. This approach is being studied for its potential influence on nervous system activity and symptoms associated with Long COVID, although research remains ongoing.
Dr. Elisabetta Burchi, Translational Research Lead at Parasym, has discussed the possible role of neural networks involved in memory and attention, noting that this pathway “has probably underpinned the positive clinical effects we have reported in controlled clinical trials conducted in Long COVID patients.”
The resource distinguishes general research into vagus nerve stimulation from findings involving Parasym's proprietary AVNT technology. Across specific clinical study populations, researchers have reported measurable changes in nervous system activity and symptoms. In clinical studies, vagus nerve activity increased by an average of 61%. Furthermore, in clinical studies, fatigue fell by an average of 48%.
Nuropod is a wearable vagus nerve stimulation device that clips onto the tragus, where a branch of the vagus nerve reaches the skin of the ear. It delivers gentle electrical pulses using Parasym's proprietary AVNT waveform and is designed for daily use alongside existing care, not as a replacement for existing care.
About Nuropod
Launched in the United States in September 2025, Nuropod is a wearable vagus nerve stimulation device built around Parasym's proprietary AVNT™ waveform. The technology is supported by more than 60 completed clinical studies, more than 100 ongoing studies, more than 150 research partners, and over 10 years of research and development. Nuropod is FCC compliant and is a wellness device, not a medical device.
The full resource is available at https://nuropod.com/blogs/articles/vagus-nerve-and-long-covid-symptoms-research-nervous-system-connection
Disclaimer: Research referenced in this article was conducted using Parasym’s neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-designated risk device and is not intended to diagnose, treat, cure, or prevent any disease.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nuropod by Parasym
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/
Source: PressCable
Release ID: 89210198
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
Source: MarketersMedia


Leave a comment
Comments are closed on this post.